Immunosuppressive drugs in immune and inflammatory ocular disease
- PMID: 2038720
- DOI: 10.1016/0039-6257(91)90186-j
Immunosuppressive drugs in immune and inflammatory ocular disease
Erratum in
-
Chlorambucil dosage should never exceed 22 mg/day: correction of typographical error.Surv Ophthalmol. 1991 May-Jun;35(6):475. doi: 10.1016/0039-6257(91)90114-u. Surv Ophthalmol. 1991. PMID: 1882325 No abstract available.
Abstract
Advances in immunology, particularly ocular immunology, have been accompanied by the emergence of safer, more specific immunosuppressive drugs, notably, cyclophosphamide, chlorambucil, methotrexate, azathioprine, cyclosporine A, bromocriptine, dapsone, and colchicine. These drugs have become an important, and often essential, part of the ophthalmologist's armamentarium against inflammatory and immune-mediated ocular diseases. In order to better acquaint the ophthalmologist with the properties of the most commonly used immunosuppressive drugs, we review the literature and relate our own experience with these agents.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
